NPCE
USDNeuropace Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.800
High
$12.032
Low
$11.110
Volume
0.33M
Company Fundamentals
Market Cap
368.3M
Industry
Medical devices
Country
United States
Trading Stats
Avg Volume
0.29M
Exchange
NGM
Currency
USD
52-Week Range
Related News
NeuroPace Secures Up to $75 Million in Debt Financing
MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has
HC Wainwright & Co. Initiates Coverage On NeuroPace with Buy Rating, Announces Price Target of $18
HC Wainwright & Co. analyst Yi Chen initiates coverage on NeuroPace with a Buy rating and announces Price Target of $18.
NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.